Cite
HARVARD Citation
Wang, X. et al. (2021). Tolerance and Pharmacokinetics of Recombinant Human Endostatin Administered as Single-Dose or Multiple-Dose Infusions in Patients With Advanced Solid Tumors: A Phase I Clinical Trial. Technology in cancer research & treatment. p. . [Online].